Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
I have never felt any pressure to do anything, if anything, they tend to start small and make sure their clients are happy and getting what they want
Clinical trial data from the SURMOUNT-1 study showed that gastrointestinal adverse events were significantly more common during dose escalation periods (Jastreboff et al., 2022, NEJM)
Monitoring: Metabolic: Monitor for signs/symptoms of hypoglycemia GI: Monitor for signs/symptoms of pancreatitis after starting therapy Renal: Monitor renal function in patients with renal dysfunction reporting severe adverse GI reactions (especially when starting or escalating doses) Patient advice: Read the US FDA-approved patient labeling (Medication Guide and Instructions for Use)
Overall, this experience was expensive, unsatisfactory and ultimately useless
What Causes Them to Occur for Children
US$ 24.64
US$ 22.43
US$ 27.41
US$ 27.65
